Double burst stimulation2,3: a new stimulating pattern for residual neuromuscular block.
OBJECTIVE
We present a new stimulating pattern: double burst stimulation2,3 (DBS2,3) for evaluating residual neuromuscular block.


METHODS
Forty adult patients were studied. For DBS2,3, two burst stimuli were applied every 750 msec. The first consisted of two tetanic stimuli of 0.2 msec duration and the second of three tetanic stimuli of 0.2 msec duration. At varying degrees of neuromuscular block induced by vecuronium, the presence or absence of fade, or the presence or absence of waxing (i.e., the feeling that the muscular contraction in response to the second burst was stronger than that to the first) was determined by an observer blinded to the depth of neuromuscular block. In addition, the relationship between the train-of-four (TOF) ratio and DBS2,3 ratio was established at varying depths of neuromuscular block (TOF ratio 0.04-1.00).


RESULTS
The probabilities of tactile detection of fade in response to DBS2,3 were 100, 76, 15, 9, 3, 0, and 0% at a TOF ratio of 0-0.40, 0.41-0.50, 0.51-0.60, 0.61-0.70, 0.71-0.80, 0.81-0.90, and 0.91-1.00, respectively. Waxing in response to the DBS2,3 was identified in 0, 6, 32, 84, and 98% of cases when the TOF ratios were 0.00-0.60, 0.61-0.70, 0.71-0.80, 0.81-0.90, and 0.91-1.00, respectively. A close linear relationship existed between the TOF ratio and DBS2,3 ratio (r = 0.96, P < 0.000001).


CONCLUSIONS
DBS2,3 is of clinical use because when residual neuromuscular block is clinically important, fade can be identified, but once neuromuscular function returns to a sufficient level, waxing can be detected.
Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
Y
Y
Saitoh
K
K
Nakazawa
H
H
Tanaka
H
H
Toyooka
K
K
Amaha
D000328:Adult; D000368:Aged; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D014673:Vecuronium Bromide / Q000494:pharmacology*
D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide